SEC Form 3 · accession 0000899243-16-030379
T2 Biosystems, Inc. · TTOO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Sep 21, 2016
Accepted (ET)
Sep 30, 2016 · 6:05 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492674
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 6,055,341 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares are owned directly by Canon U.S.A., Inc., which is a wholly owned subsidiary of Canon Inc. Canon Inc. is an indirect beneficial owner of the reported securities.